Skip to main content

ALISKIREN

Tracking # 20-1024714

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

ALISKIREN IS A DIRECT RENIN INHIBITOR MEDICATION THAT IS FDA APPROVED TO TREAT HYPERTENSION IN ADULTS AND CHILDREN SIX YEARS AND OLDER. IT MAY BE USED AS MONOTHERAPY OR IN COMBINATION WITH OTHER ANTIHYPERTENSIVE AGENTS. THIS ACTIVITY REVIEWS THE INDICATIONS, CONTRAINDICATIONS, ACTIVITY, ADVERSE EVENTS, MECHANISM OF ACTION, AND OTHER CRITICAL ELEMENTS OF ALISKIREN USE IN HYPERTENSION MANAGEMENT AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN MANAGING THE CARE OF PATIENTS RECEIVING THERAPY WITH ALISKIREN.

Subject areas

This course counts toward the state boards and subject areas below.

Arkansas State Board of Nursing

Certified Nurse Midwife

1h Practice-Focused Continuing Education

Certified Nurse Practitioner

1h Practice-Focused Continuing Education

Certified Registered Nurse Anesthetist

1h Practice-Focused Continuing Education

Clinical Nurse Specialist

1h Practice-Focused Continuing Education

Licensed Practical Nurse

1h Practice-Focused Continuing Education

Licensed Psychiatric Technician Nurse

1h Practice-Focused Continuing Education

Registered Nurse

1h Practice-Focused Continuing Education

Registered Nurse Practitioner

1h Practice-Focused Continuing Education

District of Columbia Board of Nursing

Licensed Practical Nurse

1h Licensed Practical Nurse - Continuing Education

Registered Nurse

1h Pharmacology Component

Georgia Board of Nursing

Licensed Practical Nurse

1h General

Registered Professional Nurse

1h General

South Carolina Board of Nursing

Advanced Practice Registered Nurse

1h Pharmacotherapeutics

Licensed Practical Nurse

1h Pharmacotherapeutics

Registered Nurse

1h Pharmacotherapeutics

West Virginia Board of Registered Nurses

Advanced Practice Registered Nurse

1h Relating to professional nursing practice